As a leading manufacturer with years of experience in the API industry, we are committed to providing high-compliance, high-stability, and cost-effective Semaglutide Raw Powder (CAS 910463-68-2) to B2B clients worldwide. Leveraging globally advanced dual production technologies (total synthesis and recombination), we develop core raw materials suitable for pharmaceutical formulations, scientific research experiments, and compliant export, helping clients seize opportunities in the GLP-1 drug market. We deeply understand the core needs of B2B procurement-controllable quality, stable supply, complete qualifications, and cost optimization. Therefore, from raw material selection to finished product delivery, we strictly follow GMP production standards, with each batch of Semaglutide Raw Powder undergoing comprehensive testing, accompanied by complete compliance documents such as COA and MSDS. We offer one-stop supply services ranging from gram-level samples to ton-level bulk orders, and have become the preferred partner for pharmaceutical companies and research institutions in the Middle East, Europe, America, Southeast Asia and other regions, building a solid foundation for cooperation with strength and professionalism.
Core Advantages
1.Controllable High Purity: Adopting multi-stage purification technology, the High Purity Semaglutide Powder maintains stable purity of ≥99%, with strictly controlled impurities, no harmful residues, certified by authoritative third-party institutions, and traceable quality of each batch, which can perfectly meet the needs of high-end pharmaceutical formulation production and precision scientific research.
2. Dual-Process Supply Capacity: As a manufacturer with both total synthesis and recombination production processes, we have an annual production capacity of up to ton-level, which can flexibly meet the diverse needs of customers-fast supply of small-batch samples (10g-100g) and stable delivery of bulk orders (1kg-25kg and above), without stock-out concerns, ensuring the stability of customer supply chains.
3. Comprehensive Compliance Guarantee: Strictly follow international pharmaceutical raw material control standards, clearly mark the product purpose as "for pharmaceutical R&D, scientific research and legal export only", and avoid regulatory risks. Wegovy and Ozempic-related brand terms are only used for product attribute description, not for direct marketing. We can provide complete compliance documents such as DMF, GMP certification, COA and MSDS to ensure smooth export of products to more than 50 countries and regions around the world.
4. Stable Form and Strong Adaptability: Semaglutide Raw Powder is presented as white crystalline powder with good fluidity, easy to store and dissolve, suitable for R&D and production of various downstream dosage forms such as injections and oral preparations, and can also be customized into lyophilized form (Semaglutide Lyophilized Powder) according to customer needs, adapting to diverse application scenarios.
5. High Cost-Effectiveness and Direct Supply: Direct supply from the source manufacturer, no intermediate links, which can effectively reduce customer procurement costs; exclusive discounts are available for bulk purchases, and long-term cooperative customers can enjoy priority supply, price preferences and other value-added services, helping customers improve product competitiveness.
6. Professional Technical Support: We have a professional R&D and technical team that can provide full-process technical guidance on product application, formulation R&D and export compliance, and solve technical problems encountered by customers in the production and research process in a timely manner.
Compliance Statement
This product is Semaglutide API raw material, only for pharmaceutical R&D, scientific research experiments and legal export, not for personal sale or direct human consumption. Illegal addition to food, health supplements and other products is strictly prohibited.
2. Wegovy and Ozempic are brand terms related to Semaglutide, which are only used to describe product attributes and not for direct marketing to avoid brand infringement risks.
3. Semaglutide has been included in the relevant control scope of various countries. Customers are required to provide legal use certificates when purchasing, and we only supply compliant B2B clients (pharmaceutical companies, research institutions, etc.), and strictly review the qualification of cooperative clients to ensure legal and compliant cooperation.
